SCHEMBL29081663

SCHEMBL29081663

CC1CC[C@@H](c2cc(F)c(F)c(F)c2)NC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24365608 1.00 — —
SCHEMBL24363860 1.00 — —
SCHEMBL25321659 0.97 — —
SCHEMBL29081977 0.89 CYP2D6 (0.32) —
SCHEMBL29324035 0.89 CYP2D6 (0.32) —
SCHEMBL24365460 0.89 CYP2D6 (0.32) —
SCHEMBL31145112 0.86 ESR2 (0.30) —
SCHEMBL24364670 0.86 ESR2 (0.30) —
SCHEMBL24367120 0.84 — —
SCHEMBL25319916 0.83 KDM1A (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116568677-A piperidin-1-yl-N-pyridin-3-yl-2-oxoacetamide derivatives useful for the treatment of MTAP deficiency and/or MTA accumulating cancers 探戈医药股份有限公司 2023-08-08 — — CN disclosed
Send feedback